The Current Strategy in Hormonal and Non-Hormonal Therapies in Menopause—A Comprehensive Review

AL Pop, BA Nasui, RG Bors, ON Penes, AG Prada… - Life, 2023 - mdpi.com
Menopause is a natural stage of hormonal aging in women, accompanied by a series of
symptoms that reduce the quality of life of a fully active person. As no therapy is entirely …

A pragmatic approach to the management of menopause

IC Lega, A Fine, ML Antoniades, M Jacobson - CMAJ, 2023 - Can Med Assoc
• Menopausal symptoms can occur for as long as 10 years before the last menstrual period
and are associated with substantial morbidity and negative impacts on quality of life.• …

Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study

J Lu, K Li, X Zheng, R Liu, M Chen, J Xian, S Tu… - BMC Women's …, 2023 - Springer
Background Menopause is a specific physical and psychological transition period for
women, during which they experience a series of menopausal symptoms. Menopausal …

Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial

JC Prior, A Cameron, M Fung, CL Hitchcock… - Scientific Reports, 2023 - nature.com
This study tested progesterone for perimenopausal hot flush±night sweat (vasomotor
symptom, VMS) treatment. It was a double-blind, randomized trial of 300 mg oral micronized …

Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: a systematic review and meta‐analysis of randomized controlled trials

SMM Akhtar, A Ali, MS Khan, V Khan… - … of Gynecology & …, 2024 - Wiley Online Library
Background Vasomotor symptoms (VMS), such as hot flashes and night sweats, are highly
prevalent and burdensome for women experiencing menopausal transition. Fezolinetant, a …

Women's perceptions and experiences with cannabis use in menopause: a qualitative study

K Babyn, M Quintanilha, S Ross, M Makowsky… - Menopause, 2024 - journals.lww.com
Objectives Since the legalization of recreational cannabis in 2018, the use of cannabis for
medical reasons has increased in Canada. The aim of this study was to explore the …

[HTML][HTML] Hormones and thrombosis: the dark side of the moon

D Barcellona, E Grandone, F Marongiu - Blood Transfusion, 2024 - ncbi.nlm.nih.gov
Background The main drawback of oral contraceptives (OC) and hormone replacement
therapy (HRT) is an increased risk of venous and, to a lesser extent, arterial thrombosis …

Cannabis use for menopause in women aged 35 and over: a cross-sectional survey on usage patterns and perceptions in Alberta, Canada

K Babyn, S Ross, M Makowsky, T Kiang, N Yuksel - BMJ open, 2023 - bmjopen.bmj.com
Objective Use of cannabis for medical reasons has increased in Canada since legalisation
of recreational cannabis in 2018. The objective of this study was to examine the pattern of …

Development and validation of a case definition for problematic menopause in primary care electronic medical records

ANQ Pham, M Cummings, N Yuksel, B Sydora… - BMC medical informatics …, 2023 - Springer
Background Menopause is a normal transition in a woman's life. For some women, it is a
stage without significant difficulties; for others, menopause symptoms can severely affect …

A systematic review and critical appraisal of menopause guidelines

C Hemachandra, S Taylor, RM Islam… - BMJ Sexual & …, 2024 - srh.bmj.com
Objective and rationale To identify and appraise current national and international clinical
menopause guidance documents, and to extract and compare the recommendations of the …